<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(11)</volume><submitter>Na YJ</submitter><pubmed_abstract>Despite the importance of radiation therapy, there are few radiation-related markers available for use in clinical practice. A larger catalog of such biomarkers is required to help clinicians decide when radiotherapy should be replaced with a patient-specific treatment. Arachidonate 15-lipoxygenase (15-LOX-1) enzyme is involved in polyunsaturated fatty acid metabolism. When colorectal cancer (CRC) cells were exposed to radiation, 15-LOX-1 was upregulated. To verify whether 15-LOX-1 protects against or induces DNA damage, we irradiated sh15-LOX-1 stable cells. We found that low 15-LOX-1 is correlated with radioresistance in CRC cells. These data suggest that the presence of 15-LOX-1 can be used as a marker for radiation-induced DNA damage. Consistent with this observation, gene-set-enrichment analysis based on microarray experiments showed that UV_RESPONSE was decreased in sh15-LOX-1 cells compared to shCon cells. Moreover, we discovered that the expression of the histone H2A variant macroH2A2 was sevenfold lower in sh15-LOX-1 cells. Overall, our findings present mechanistic evidence that macroH2A2 is transcriptionally regulated by 15-LOX-1 and suppresses the DNA damage response in irradiated cells by delaying H2AX activation.</pubmed_abstract><journal>Cancers</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6896202</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Deficiency of 15-LOX-1 Induces Radioresistance through Downregulation of MacroH2A2 in Colorectal Cancer.</pubmed_title><pmcid>PMC6896202</pmcid><pubmed_authors>Kim BR</pubmed_authors><pubmed_authors>Kim JY</pubmed_authors><pubmed_authors>Lee DH</pubmed_authors><pubmed_authors>Kim JL</pubmed_authors><pubmed_authors>Kim HJ</pubmed_authors><pubmed_authors>Kang S</pubmed_authors><pubmed_authors>Jeong YA</pubmed_authors><pubmed_authors>Na YJ</pubmed_authors><pubmed_authors>Park SH</pubmed_authors><pubmed_authors>Jo MJ</pubmed_authors><pubmed_authors>Oh SC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Deficiency of 15-LOX-1 Induces Radioresistance through Downregulation of MacroH2A2 in Colorectal Cancer.</name><description>Despite the importance of radiation therapy, there are few radiation-related markers available for use in clinical practice. A larger catalog of such biomarkers is required to help clinicians decide when radiotherapy should be replaced with a patient-specific treatment. Arachidonate 15-lipoxygenase (15-LOX-1) enzyme is involved in polyunsaturated fatty acid metabolism. When colorectal cancer (CRC) cells were exposed to radiation, 15-LOX-1 was upregulated. To verify whether 15-LOX-1 protects against or induces DNA damage, we irradiated sh15-LOX-1 stable cells. We found that low 15-LOX-1 is correlated with radioresistance in CRC cells. These data suggest that the presence of 15-LOX-1 can be used as a marker for radiation-induced DNA damage. Consistent with this observation, gene-set-enrichment analysis based on microarray experiments showed that UV_RESPONSE was decreased in sh15-LOX-1 cells compared to shCon cells. Moreover, we discovered that the expression of the histone H2A variant macroH2A2 was sevenfold lower in sh15-LOX-1 cells. Overall, our findings present mechanistic evidence that macroH2A2 is transcriptionally regulated by 15-LOX-1 and suppresses the DNA damage response in irradiated cells by delaying H2AX activation.</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Nov</publication><modification>2021-02-20T19:26:29Z</modification><creation>2020-05-21T23:55:04Z</creation></dates><accession>S-EPMC6896202</accession><cross_references><pubmed>31717983</pubmed><doi>10.3390/cancers11111776</doi></cross_references></HashMap>